vs

Side-by-side financial comparison of BeOne Medicines Ltd. (ONC) and Worthington Steel, Inc. (WS). Click either name above to swap in a different company.

BeOne Medicines Ltd. is the larger business by last-quarter revenue ($1.5B vs $871.9M, roughly 1.7× Worthington Steel, Inc.). BeOne Medicines Ltd. runs the higher net margin — 4.4% vs 2.2%, a 2.3% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs 18.0%). BeOne Medicines Ltd. produced more free cash flow last quarter ($379.8M vs $74.6M). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs 3.9%).

BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.

Worthington Enterprises, Inc. is an American industrial manufacturing company headquartered in Columbus, Ohio. The company is composed of two business segments, consumer products and building products. Within these segments, the company designs and manufactures pressure vessels such as propane, oxygen and helium tanks, refrigerant and industrial cylinders, camping and residential use cylinders, water system tanks for storage, treatment, heating, expansion and flow control, as well as a variet...

ONC vs WS — Head-to-Head

Bigger by revenue
ONC
ONC
1.7× larger
ONC
$1.5B
$871.9M
WS
Growing faster (revenue YoY)
ONC
ONC
+14.9% gap
ONC
32.8%
18.0%
WS
Higher net margin
ONC
ONC
2.3% more per $
ONC
4.4%
2.2%
WS
More free cash flow
ONC
ONC
$305.2M more FCF
ONC
$379.8M
$74.6M
WS
Faster 2-yr revenue CAGR
ONC
ONC
Annualised
ONC
41.2%
3.9%
WS

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
ONC
ONC
WS
WS
Revenue
$1.5B
$871.9M
Net Profit
$66.5M
$18.8M
Gross Margin
90.5%
10.7%
Operating Margin
12.4%
2.5%
Net Margin
4.4%
2.2%
Revenue YoY
32.8%
18.0%
Net Profit YoY
143.8%
46.9%
EPS (diluted)
$0.05
$0.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ONC
ONC
WS
WS
Q4 25
$1.5B
$871.9M
Q3 25
$1.4B
$872.9M
Q2 25
$1.3B
$832.9M
Q1 25
$1.1B
$687.4M
Q4 24
$1.1B
$739.0M
Q3 24
$1.0B
$834.0M
Q2 24
$929.2M
Q1 24
$751.7M
$805.8M
Net Profit
ONC
ONC
WS
WS
Q4 25
$66.5M
$18.8M
Q3 25
$124.8M
$36.8M
Q2 25
$94.3M
$55.7M
Q1 25
$1.3M
$13.8M
Q4 24
$-151.9M
$12.8M
Q3 24
$-121.3M
$28.4M
Q2 24
$-120.4M
Q1 24
$-251.2M
$49.0M
Gross Margin
ONC
ONC
WS
WS
Q4 25
90.5%
10.7%
Q3 25
86.1%
13.2%
Q2 25
87.5%
15.2%
Q1 25
85.2%
11.8%
Q4 24
85.8%
10.8%
Q3 24
83.0%
12.0%
Q2 24
85.1%
Q1 24
83.4%
14.9%
Operating Margin
ONC
ONC
WS
WS
Q4 25
12.4%
2.5%
Q3 25
11.5%
5.5%
Q2 25
6.7%
8.0%
Q1 25
1.0%
2.7%
Q4 24
-7.0%
2.6%
Q3 24
-12.0%
5.2%
Q2 24
-11.5%
Q1 24
-34.8%
8.2%
Net Margin
ONC
ONC
WS
WS
Q4 25
4.4%
2.2%
Q3 25
8.8%
4.2%
Q2 25
7.2%
6.7%
Q1 25
0.1%
2.0%
Q4 24
-13.5%
1.7%
Q3 24
-12.1%
3.4%
Q2 24
-13.0%
Q1 24
-33.4%
6.1%
EPS (diluted)
ONC
ONC
WS
WS
Q4 25
$0.05
$0.37
Q3 25
$0.08
$0.72
Q2 25
$0.06
$1.11
Q1 25
$0.00
$0.27
Q4 24
$-0.10
$0.25
Q3 24
$-0.09
$0.56
Q2 24
$-0.09
Q1 24
$-0.19
$0.98

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ONC
ONC
WS
WS
Cash + ST InvestmentsLiquidity on hand
$4.5B
$89.8M
Total DebtLower is stronger
$836.4M
$72.1M
Stockholders' EquityBook value
$4.4B
$1.1B
Total Assets
$8.2B
$2.1B
Debt / EquityLower = less leverage
0.19×
0.06×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ONC
ONC
WS
WS
Q4 25
$4.5B
$89.8M
Q3 25
$4.0B
$78.3M
Q2 25
$2.8B
$38.0M
Q1 25
$2.5B
$63.3M
Q4 24
$2.6B
$52.0M
Q3 24
$2.7B
$36.0M
Q2 24
$2.6B
Q1 24
$2.8B
$60.8M
Total Debt
ONC
ONC
WS
WS
Q4 25
$836.4M
$72.1M
Q3 25
$73.4M
Q2 25
$151.5M
Q1 25
Q4 24
$115.0M
Q3 24
$122.2M
Q2 24
Q1 24
$147.2M
Stockholders' Equity
ONC
ONC
WS
WS
Q4 25
$4.4B
$1.1B
Q3 25
$4.1B
$1.1B
Q2 25
$3.8B
$1.1B
Q1 25
$3.5B
$1.0B
Q4 24
$3.3B
$1.0B
Q3 24
$3.4B
$1.0B
Q2 24
$3.4B
Q1 24
$3.4B
$937.6M
Total Assets
ONC
ONC
WS
WS
Q4 25
$8.2B
$2.1B
Q3 25
$7.6B
$2.2B
Q2 25
$6.3B
$2.0B
Q1 25
$5.8B
$1.8B
Q4 24
$5.9B
$1.7B
Q3 24
$5.8B
$1.8B
Q2 24
$5.7B
Q1 24
$5.7B
$1.8B
Debt / Equity
ONC
ONC
WS
WS
Q4 25
0.19×
0.06×
Q3 25
0.07×
Q2 25
0.14×
Q1 25
Q4 24
0.11×
Q3 24
0.12×
Q2 24
Q1 24
0.16×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ONC
ONC
WS
WS
Operating Cash FlowLast quarter
$417.3M
$99.3M
Free Cash FlowOCF − Capex
$379.8M
$74.6M
FCF MarginFCF / Revenue
25.4%
8.6%
Capex IntensityCapex / Revenue
2.5%
2.8%
Cash ConversionOCF / Net Profit
6.28×
5.28×
TTM Free Cash FlowTrailing 4 quarters
$941.7M
$72.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ONC
ONC
WS
WS
Q4 25
$417.3M
$99.3M
Q3 25
$402.6M
$-6.3M
Q2 25
$263.6M
$53.9M
Q1 25
$44.1M
$53.8M
Q4 24
$75.2M
$68.0M
Q3 24
$188.4M
$54.6M
Q2 24
$-95.6M
Q1 24
$-308.6M
$44.7M
Free Cash Flow
ONC
ONC
WS
WS
Q4 25
$379.8M
$74.6M
Q3 25
$354.5M
$-35.7M
Q2 25
$219.8M
$8.4M
Q1 25
$-12.3M
$25.2M
Q4 24
$-17.3M
$33.2M
Q3 24
$54.7M
$33.1M
Q2 24
$-205.5M
Q1 24
$-465.1M
$22.3M
FCF Margin
ONC
ONC
WS
WS
Q4 25
25.4%
8.6%
Q3 25
25.1%
-4.1%
Q2 25
16.7%
1.0%
Q1 25
-1.1%
3.7%
Q4 24
-1.5%
4.5%
Q3 24
5.5%
4.0%
Q2 24
-22.1%
Q1 24
-61.9%
2.8%
Capex Intensity
ONC
ONC
WS
WS
Q4 25
2.5%
2.8%
Q3 25
3.4%
3.4%
Q2 25
3.3%
5.5%
Q1 25
5.0%
4.2%
Q4 24
8.2%
4.7%
Q3 24
13.3%
2.6%
Q2 24
11.8%
Q1 24
20.8%
2.8%
Cash Conversion
ONC
ONC
WS
WS
Q4 25
6.28×
5.28×
Q3 25
3.22×
-0.17×
Q2 25
2.79×
0.97×
Q1 25
34.71×
3.90×
Q4 24
5.31×
Q3 24
1.92×
Q2 24
Q1 24
0.91×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ONC
ONC

Segment breakdown not available.

WS
WS

Direct$844.1M97%
Toll$27.8M3%

Related Comparisons